This experiment turned out to be underpowered but in this aggressive bladder cancer model, a lower number of tumor-positive rats after treatment with TLR-7 agonists indicate a promising potential for the treatment of non-muscle invasive bladder cancer. The gene discussed is TLR7; the disease is urinary bladder cancer.